Mercados españoles cerrados

Hepion Pharmaceuticals, Inc. (336.MU)

Munich - Munich Precio demorado. Divisa en EUR
Añadir a la lista de favoritos
1,13000,0000 (0,00%)
A partir del 08:04AM CEST. Mercado abierto.

Transacciones de accionistas miembros de la empresa

Divisa en EUR
Compras de personas con información privilegiada de los 6 últimos mesesAccionesTrans
Compras00
VentasN/A0
Cuotas netas adquiridas (vendidas)00
Acciones de persona con información privilegiada totales5,91kN/A
% de acciones netas adquiridas (vendidas)N/AN/A
Compras institucionales netas del trimestre anterior al último trimestreAcciones
Cuotas netas adquiridas (vendidas)N/A
% de cambio en la posesión de acciones institucionalesN/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiadaTransacciónTipoValorFechaAcciones

WIJNGAARD PETER
Director

Purchase at price 3.05 - 3.09 per share.Directo15.35027 nov 20235.000

WIJNGAARD PETER
Director

Purchase at price 5.37 - 5.82 per share.Directo16.84119 sept 20233.000

FOSTER ROBERT T PH.D.
Chief Executive Officer

Purchase at price 5.60 per share.Directo8.96018 sept 20231.600

FOSTER ROBERT T PH.D.
Chief Executive Officer

Purchase at price 5.40 per share.Directo8.64015 sept 20231.600

CAVAN JOHN T
Chief Financial Officer

Purchase at price 2.00 per share.Directo20.00018 feb 202110.000

FOSTER ROBERT T PH.D.
Chief Executive Officer

Purchase at price 2.00 per share.Directo40.00018 feb 202120.000

WIJNGAARD PETER
Director

Purchase at price 2.20 per share.Directo22.00016 feb 202110.000

WIJNGAARD PETER
Director

Purchase at price 1.91 per share.Directo38.20018 dic 202020.000

FOSTER ROBERT T PH.D.
Chief Executive Officer

Purchase at price 1.58 per share.Directo39.41808 dic 202025.000

BRANCACCIO JOHN P
Director

Purchase at price 1.53 per share.Directo10.71002 dic 20207.000

JACOB GARY S
Director

Purchase at price 1.66 per share.Directo19.92001 dic 202012.000

CAVAN JOHN T
Chief Financial Officer

Purchase at price 1.62 per share.Directo7.29025 nov 20204.500

CAVAN JOHN T
Chief Financial Officer

Directo03 ene 2018101.221

SAPIRSTEIN JAMES E
Chief Executive Officer

Directo03 ene 2018322.092

FOSTER ROBERT T PH.D.
Officer

Directo03 ene 2018100.654

CAVAN JOHN T
Chief Financial Officer

Directo06 jul 201746.726

SAPIRSTEIN JAMES E
Chief Executive Officer

Directo06 jul 2017141.061

SULLIVAN-BOLYAI JOHN Z.
Officer

Directo06 jul 201758.681

FOSTER ROBERT T PH.D.
Officer

Directo06 jul 201744.082

CAVAN JOHN T
Chief Financial Officer

Purchase at price 0.65 per share.Directo13.00020 jun 201720.000

SAPIRSTEIN JAMES E
Chief Executive Officer

Conversion of Exercise of derivative security at price 1.50 per share.Directo24.99927 oct 201616.666

SAPIRSTEIN JAMES E
Chief Executive Officer

Purchase at price 1.00 per share.Directo10.00018 feb 201610.000

SAPIRSTEIN JAMES E
Chief Executive Officer

Purchase at price 2.15 per share.Directo1.07530 nov 2015500

SAPIRSTEIN JAMES E
Chief Executive Officer

Purchase at price 1.64 per share.Directo4.10023 nov 20152.500

BRANCACCIO JOHN P
Director

Purchase at price 1.49 per share.Directo6.54604 mar 20144.393